Annual Drug Patent Expirations for CLOBEX
Clobex is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs. It is available from four suppliers. There is one patent protecting this drug and three Paragraph IV challenges.
Drug patent litigation for CLOBEX.
This drug has thirty-one patent family members in twenty-one countries.
The generic ingredient in CLOBEX is clobetasol propionate. Four suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
